Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study

Fig. 4

Lifetime cost and quality-adjusted life-year (QALY) of gastric cancer screening strategies compared with no screening. Note: Screening strategies are indicated as starting age-stopping age-screening interval. Costs and QALYs were discounted at an annual rate of 3%. An incremental cost-effectiveness ratio is shown for each strategy on the cost-effectiveness frontier

Back to article page